Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
0.945 USD | +2.41% | -0.21% | -31.04% |
26/04 | Bluebird bio Gets Nasdaq Notice for Late Filing of Annual Report | MT |
27/03 | Wells Fargo Trims Price Target on Bluebird Bio to $3 From $4, Maintains Equalweight Rating | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-31.04% | 178M | |
-2.60% | 103B | |
+1.70% | 95.28B | |
+1.46% | 22.15B | |
-15.58% | 21.02B | |
-8.58% | 18.15B | |
-38.74% | 16.73B | |
-12.50% | 16.05B | |
+5.40% | 13.68B | |
+34.44% | 12.17B |
- Stock Market
- Equities
- BLUE Stock
- News bluebird bio, Inc.
- bluebird bio : Morgan Stanley Adjusts bluebird bio PT to $45 From $50, Maintains Equal Weight Rating